Ivantis Completes Its $33 Million Stock Offering

Represented Ivantis, Inc. in its $33 Million Series B Preferred Stock venture round. Read the article.

Related Practices

Related Industries & Initiatives

Life Science

Related Attorneys

Of Counsel

Venture Capital